Global Hepatitis Test Solution Industry - Competitive Situation & Trends
Summary
- Global Hepatitis Test Solution Market overview.
- GEOGRAPHIC ANALYSIS: Hepatitis Test Solution Market, BY DISEASE TYPE (2018).
- Hepatitis Test Solution Market, BY TECHNOLOGY, 2018 VS. 2023.
- Hepatitis Test Solution Market, BY END USER, 2016–2023.
Target Audience:
# Blood banks
# Pathologists and pathology laboratories
# Distributors of IVD products
# Research institutes
# Hospitals and clinics
# Healthcare institutions
# Group purchasing organizations (GPOs)
# Market research and consulting firms
Global Geographical Scenario:
North America is expected to dominate the Hepatitis Test Solution Market in 2018
North America is expected to account for the largest share of the global hepatitis test solution/diagnosis market in 2018. The large share of the North America region is primarily attributed to factors such as the rising adoption of advanced technologies, developed healthcare systems in the US and Canada, and the presence of a large number of leading national clinical laboratories.
The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the hepatitis test solution/diagnosis market in this region is driven by the modernization of healthcare infrastructure, high burden of hepatitis infections, increased healthcare spending by a larger population base, and the rising penetration of cutting-edge clinical laboratory technologies.
What the Market Looks Like?
The global hepatitis test solution/diagnosis market is expected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, at a CAGR of 4.9% during the forecast period (2018–2023).
Download PDF Brochure @ Download PDF Brochure - Hepatitis Test Solution Market by Technology, Disease Type & End User 2023 | MarketsandMarkets
Major Leaders:
The key players operating in this market include Abbott Laboratories (US), Roche (Switzerland), Bio-Rad (US), Siemens (Germany), DiaSorin (OTCPK:ITALY), QIAGEN (Netherlands), bioMérieux (France), Danaher (US), and Grifols (Spain).
Collaborations, agreements, and partnerships remain at the center of the strategic growth initiatives adopted by most of the key players in the global hepatitis test solution/diagnosis market. Companies such as Abbott Laboratories, Roche Diagnostics, Bio-Rad, DiaSorin, Danaher, and Grifols have been focusing on this inorganic strategy to enhance their market presence. Players also adopted product launches, product approval, and acquisition as growth strategies.
What Drives the Market?
The growth of the global Hepatitis Test Solution Industry is primarily influenced by the following factors:
# High burden of hepatitis
# Increasing blood transfusion and donations
# Benefits of PoC instruments & kits
# Awareness initiatives
Feel FREE to Connect to Our Research Experts for More Detailed Information@
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.